Mycophenolate‐based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative‐related donor stem cell transplantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|90|5|392-399

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.5, 2015-05, pp. : 392-399

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA‐identical sibling donor allogeneic hematopoietic cell transplantation

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 2, 2015-02 ,pp. : 144-148

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mycophenolate mofetil for treatment of steroid‐refractory acute graft‐versus‐host disease after pediatric hematopoietic stem cell transplantation

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 6, 2015-09 ,pp. : 652-658

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomised Trials of Graft Versus Host Disease Prophylaxis in Haemopoietic Stem Cell Transplantation

Reviews on Recent Clinical Trials, Vol. 3, Iss. 2, 2008-05 ,pp. : 130-138

Bentham Science Publishers

Access to resources Recommend Favorite

The efficacy and safety of sirolimus‐based graft‐versus‐host disease prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation: a meta‐analysis of randomized controlled trials

TRANSFUSION, Vol. 41-1132, Iss. 9, 2015-09 ,pp. : 2134-2141

John Wiley & Sons Inc

Access to resources Recommend Favorite

TRANSFUSION, Vol. 55, Iss. 9, 2015-09 ,pp. : 2134-2141

John Wiley & Sons Inc

Access to resources Recommend Favorite